KarX-EC

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for KarX-EC, covering 2025-12-19 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2) [Phase 3]

See pricing